ClinicalTrials.govpublic full text
Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes
postprandial hypoglycemia, sglt2-inhibitor empagliflozin, il-1 receptor antagonist anakinra, prediabetes, insulin clearance, proinsulin, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828473
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.